J.-H. Yang et al. / Tetrahedron: Asymmetry 19 (2008) 2164–2166
2165
derived from (S)-4-benzyl-1,3-thiazolidine-2-thione, the more
reactive enolate derived from the prolinol propionamide was em-
ployed in the alkylation reaction.11 Thus, the dianion of N-propio-
nylprolinol was reacted with the alkyl iodide to give 7 in 84% yield
(de = 92% for the crude alkylation products). Subsequent acid
5H); 13C NMR (125 MHz, CDCl3Þ: d 22.3, 32.0, 36.8, 47.3, 64.0,
68.2, 127.3, 128.9, 129.4, 136.3, 173.1, 201.4.
4.3. (3S)-1-[(S)-4-Benzyl-2-thioxothazolidin-3-yl]-3-(tert-
butyldimethylsilyloxy)butan-1-one 4
hydrolysis of 7 gave the desired lactone 1 in 82% yield (98% ee12
)
after column chromatography. The analytical and spectroscopic
data of the pheromone, as well as the specific rotation value were
in agreement with the literature.2
To a solution of 3 (1.06 g, 3.6 mmol) in DMF (15 mL) were added
TBSCl (2.16 g, 14.3 mmol) and 2,6-lutidine (2.1 mL, 17.9 mmol).
The solution was stirred at room temperature for 5 h. Then ice
water (60 mL) was added and the mixture was extracted with
CH2Cl2 (2 ꢂ 40 mL). The organic layer was washed with saturated
aqueous sodium bicarbonate, brine, dried over anhydrous sodium
sulfate, and concentrated in vacuo. Flash chromatography (hex-
ane/EtOAc, 100:1) provided the silyl ether 4 (1.43 g, 97% yield).
3. Conclusion
In conclusion, we have provided an effective procedure for the
stereoselective synthesis of the sex pheromone of X. hirutissima
(33% overall yield) from easily available starting materials. In this
approach, the C2 stereocenter was established by employing an
N-propionylprolinol-mediated asymmetric alkylation reaction,
the C5 stereocenter was set through an asymmetric acyl-thiazo-
lidinethione aldol reaction. Further application of this meth-
odology to the syntheses of other biologically active compounds
is currently underway in our laboratory.
Mp 72.9–73.7 °C;
½
a 2D5
ꢁ
¼ þ120:2 (c 1.220, CHCl3Þ; IR (NaCl,
cmꢀ1Þ: mmax 3027, 1700, 1602, 1168; 1H NMR (600 MHz, CDCl3Þ: d
0.06 (s, 3H), 0.09 (s, 3H), 0.85 (s, 9H), 1.24 (d, J = 5.4 Hz, 3H), 2.88
(d, J = 11.4 Hz, 1H), 3.04 (dd, J = 10.8, 13.2 Hz, 1H), 3.13 (dd,
J = 4.2, 16.2 Hz, 1H), 3.26 (dd, J = 3.6, 13.2 Hz, 1H), 3.45 (dd,
J = 6.6, 11.4 Hz, 1H), 3.57 (dd, J = 8.4, 16.2 Hz, 1H), 4.44–4.47 (m,
1H), 5.24–5.27 (m, 1H), 7.28–7.36 (m, 5H); 13C NMR (125 MHz,
CDCl3Þ: d ꢀ4.8, ꢀ4.4, 17.9, 24.1, 25.8, 32.2, 36.6, 48.0, 65.8, 68.7,
127.2, 128.9, 129.4, 136.6, 172.2, 201.1.
4. Experimental
4.1. General
4.4. (S)-3-(tert-Butyldimethylsilyloxy)-1-butanol 5
NaBH4 (1.78 g, 31.2 mmol) was added to a stirred solution of 4
(3.19 g, 7.79 mmol) in EtOH (45 mL). After stirring at room temper-
ature for 3 h, the excess NaBH4 was carefully destroyed by the
dropwise addition of 1 M HCl. The solution was removed in vacuo,
and the residue was extracted with EtOAc (3 ꢂ 30 mL). The organic
phase was washed with brine, dried over anhydrous sodium sul-
fate, and concentrated in vacuo. Flash chromatography (hexane/
All solvents were obtained from commercial sources and dried
or purified by standard procedures before use. Separations by flash
chromatography were performed on 300–400 mesh silica gel.
Melting points were measured on a WRS-1A digital melting point
apparatus and are uncorrected. Optical rotations were measured
using a sodium D line on WZZ-2B Automatic Polarimeter. HPLC
analyses were carried out on a Dionex chromatograph (Ulti-
mate3000 pump, C8 reversed-phase chromatographic column)
equipped with a diode-array UV detector. Mass spectra were re-
corded on Finnigan LCQ DUO MS system. IR spectra were recorded
on an IR-spectrum (PE) spectrometer. NMR spectra were recorded
on Varian Unity Inova 600 spectrometer in CDCl3 (1H at 600 MHz
and 13C at 125 MHz) using TMS as the internal standard.
EtOAc, 20:1) provided
5
as
a
colorless oil (1.48 g, 93%).
¼ þ25 (c 2.00, CHCl3Þ};
½
a 2D5
ꢁ
¼ þ24:6 (c 0.906, CHCl3Þ {lit.13
½ ꢁ
a 2D5
IR (NaCl, cmꢀ1Þ: mmax 3368, 1472, 1376; 1H NMR (600 MHz,
CDCl3Þ: d 0.09 (s, 3H), 0.10 (s, 3H), 0.90 (s, 9H), 1.20 (d, J = 6.0 Hz,
3H), 1.61–1.66 (m, 1H), 1.76–1.81 (m, 1H), 2.56 (s, 1H), 3.70–
3.74 (m, 1H), 3.82–3.86 (m, 1H), 4.09–4.13 (m, 1H); 13C NMR
(125 MHz, CDCl3Þ: d ꢀ5.0, ꢀ4.4, 17.9, 23.4, 25.8, 40.4, 60.4, 68.3.
4.2. (3S)-1-[(S)-4-Benzyl-2-thioxothazolidin-3-yl]-3-
4.5. (S)-3-(tert-Butyldimethylsilyloxy)butyl iodide 6
hydroxybutan-1-one 3
To a solution of 5 (1.07 g, 5.2 mmol) in CH2Cl2 (25 mL) were
added imidazole (1.06 g, 15.6 mmol), Ph3P (2.73 g, 10.4 mmol),
and I2 (2.64 g, 10.4 mmol). The solution was stirred at room tem-
perature for 3 h and then washed with saturated aqueous sodium
thiosulfate, saturated aqueous sodium bicarbonate, and brine. The
organic phase was dried over anhydrous sodium sulfate and con-
centrated in vacuo. Flash chromatography (hexane/EtOAc, 100:1)
A solution of N-acetyl (4S)-benzylthiazolidinethione (1.25 g,
4.98 mmol) in freshly distilled CH2Cl2 (30 mL) at 0 °C was treated
dropwise with a solution of TiCl4 (5.5 mL, 1 M solution in CH2Cl2,
5.48 mmol) under Ar, and the solution was allowed to stir for
20 min. To the yellow mixture was added diisopropylethylamine
(4.98 mmol, 0.83 mL), and the solution was stirred for 40 min at
provided the alkyl iodide 6 (1.52 g, 93%). ½a D25
ꢁ
¼ þ50:2 (c 0.833,
0 °C.
A solution of acetaldehyde (5.5 mL, 1.36 M in CH2Cl2,
CHCl3Þ {lit.14
½
a 2D5
ꢁ
¼ þ45:9 (c 1.66, CHCl3Þ}; IR (NaCl, cmꢀ1Þ: mmax
7.47 mmol) was transferred via cannula to the reaction mixture,
which was then stirred for 1 h at 0 °C. The reaction was quenched
with saturated ammonium chloride (30 mL), and the layers were
separated. The organic layer was dried over anhydrous sodium sul-
fate, and the solvent was removed in vacuum to afford the crude
aldol products as a mixture of diastereomers (88:12). Purification
by flash chromatography (hexane/EtOAc, 5:1) afforded 3 (0.78 g,
56%) as a yellow solid, which was recrystallized from EtOAc–petro-
leum ether to give a yellow needle crystal. Mp 75.7–76.5 °C;
2956, 2929, 2892, 2857, 1472, 1375; 1H NMR (600 MHz, CDCl3Þ: d
0.08 (s, 3H), 0.10 (s, 3H), 0.89 (s, 9H), 1.15(d, J = 6.0 Hz, 3H), 1.86–
1.96 (m, 2H), 3.18–3.26 (m, 2H), 3.86–3.91 (m, 1H); 13C NMR
(125 MHz, CDCl3Þ: d ꢀ4.6, ꢀ4.2, 3.5, 18.0, 23.5, 25.8, 43.2, 68.2.
4.6. (2R,5S)-5-(tert-Butyldimethylsilyloxy)-1-[(S)-2-
(hydroxymethyl)pyrrolidin-1-yl]-2-methylhexan-1-one 7
½
a 2D5
ꢁ
¼ þ167:2 (c 1.143, CHCl3Þ; IR (NaCl, cmꢀ1Þ: mmax 3426, 3026,
A
solution of LDA was prepared from diisopropylamine
1693, 1603, 1496, 1166; 1H NMR (600 MHz, CDCl3Þ: d 1.28 (d, J =
6.6 Hz, 3H), 2.80 (d, J = 3.6 Hz, 1H), 2.91 (d, J = 12.0 Hz, 1H), 3.05
(dd, J = 10.8, 13.2 Hz, 1H), 3.12 (dd, J = 9.3, 17.7 Hz, 1H), 3.22 (dd,
J = 3.6, 13.2 Hz, 1H), 3.41 (dd, J = 7.5, 11.1 Hz, 1H), 3.66 (dd, J = 2.4,
17.4 Hz, 1H), 4.32–4.35 (m, 1H), 5.39–5.42 (m, 1H), 7.29–7.36 (m,
(0.47 mL, 3.31 mmol) and n-BuLi (3.31 mmol) in dry THF under
Ar at 0 °C. The (S)-prolinol propionamide (0.26 g, 1.66 mmol) in
THF (1 mL) was slowly added, and the mixture was stirred at room
temperature for 30 min then cooled to ꢀ78 °C, and the iodide 6
(0.40 g, 1.27 mmol) was added. The resulting solution was slowly